Tactile Systems Technology Competitors

Tactile Systems Technology (NASDAQ:TCMD) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Profitability

This table compares Tactile Systems Technology and Glaukos' net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent recommendations and price targets for Tactile Systems Technology and Glaukos, as provided by MarketBeat.

Tactile Systems Technology presently has a consensus price target of $59.00, indicating a potential upside of 4.76%. Glaukos has a consensus price target of $66.3750, indicating a potential downside of 21.44%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, equities analysts clearly believe Tactile Systems Technology is more favorable than Glaukos.

Risk and Volatility

Tactile Systems Technology has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500. Comparatively, Glaukos has a beta of 1.87, suggesting that its share price is 87% more volatile than the S&P 500.

Earnings & Valuation

This table compares Tactile Systems Technology and Glaukos' top-line revenue, earnings per share and valuation.

Glaukos has higher revenue and earnings than Tactile Systems Technology. Glaukos is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Summary

Tactile Systems Technology beats Glaukos on 7 of the 12 factors compared between the two stocks.

Tactile Systems Technology (NASDAQ:TCMD) and Cantel Medical (NYSE:CMD) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Profitability

This table compares Tactile Systems Technology and Cantel Medical's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of recent recommendations and price targets for Tactile Systems Technology and Cantel Medical, as provided by MarketBeat.

Tactile Systems Technology presently has a consensus price target of $59.00, indicating a potential upside of 4.76%. Cantel Medical has a consensus price target of $71.50, indicating a potential downside of 16.22%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, equities analysts clearly believe Tactile Systems Technology is more favorable than Cantel Medical.

Insider and Institutional Ownership

95.0% of Cantel Medical shares are owned by institutional investors. 5.3% of Tactile Systems Technology shares are owned by company insiders. Comparatively, 10.7% of Cantel Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Tactile Systems Technology has a beta of 1.69, meaning that its stock price is 69% more volatile than the S&P 500. Comparatively, Cantel Medical has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500.

Earnings & Valuation

This table compares Tactile Systems Technology and Cantel Medical's top-line revenue, earnings per share and valuation.

Cantel Medical has higher revenue and earnings than Tactile Systems Technology. Cantel Medical is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Summary

Cantel Medical beats Tactile Systems Technology on 9 of the 14 factors compared between the two stocks.

Tactile Systems Technology (NASDAQ:TCMD) and NuVasive (NASDAQ:NUVA) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, earnings, analyst recommendations, profitability and valuation.

Analyst Ratings

This is a summary of recent recommendations and price targets for Tactile Systems Technology and NuVasive, as provided by MarketBeat.

Tactile Systems Technology presently has a consensus price target of $59.00, indicating a potential upside of 4.76%. NuVasive has a consensus price target of $64.8667, indicating a potential downside of 5.70%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, equities analysts clearly believe Tactile Systems Technology is more favorable than NuVasive.

Earnings & Valuation

This table compares Tactile Systems Technology and NuVasive's top-line revenue, earnings per share and valuation.

NuVasive has higher revenue and earnings than Tactile Systems Technology. NuVasive is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

Tactile Systems Technology has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500. Comparatively, NuVasive has a beta of 1.36, suggesting that its share price is 36% more volatile than the S&P 500.

Profitability

This table compares Tactile Systems Technology and NuVasive's net margins, return on equity and return on assets.

Summary

NuVasive beats Tactile Systems Technology on 7 of the 12 factors compared between the two stocks.

Merit Medical Systems (NASDAQ:MMSI) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Merit Medical Systems and Tactile Systems Technology, as reported by MarketBeat.com.

Merit Medical Systems presently has a consensus target price of $64.3750, indicating a potential upside of 4.27%. Tactile Systems Technology has a consensus target price of $59.00, indicating a potential upside of 4.76%. Given Tactile Systems Technology's higher probable upside, analysts clearly believe Tactile Systems Technology is more favorable than Merit Medical Systems.

Earnings and Valuation

This table compares Merit Medical Systems and Tactile Systems Technology's gross revenue, earnings per share and valuation.

Tactile Systems Technology has lower revenue, but higher earnings than Merit Medical Systems. Merit Medical Systems is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

99.5% of Merit Medical Systems shares are owned by institutional investors. 4.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 5.3% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

Merit Medical Systems has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500.

Profitability

This table compares Merit Medical Systems and Tactile Systems Technology's net margins, return on equity and return on assets.

Summary

Merit Medical Systems beats Tactile Systems Technology on 9 of the 14 factors compared between the two stocks.

AtriCure (NASDAQ:ATRC) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for AtriCure and Tactile Systems Technology, as reported by MarketBeat.com.

AtriCure presently has a consensus target price of $67.1429, indicating a potential upside of 0.83%. Tactile Systems Technology has a consensus target price of $59.00, indicating a potential upside of 4.76%. Given Tactile Systems Technology's higher probable upside, analysts clearly believe Tactile Systems Technology is more favorable than AtriCure.

Earnings and Valuation

This table compares AtriCure and Tactile Systems Technology's gross revenue, earnings per share and valuation.

Tactile Systems Technology has lower revenue, but higher earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

94.7% of AtriCure shares are owned by institutional investors. 5.8% of AtriCure shares are owned by insiders. Comparatively, 5.3% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Volatility and Risk

AtriCure has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500.

Profitability

This table compares AtriCure and Tactile Systems Technology's net margins, return on equity and return on assets.

iRhythm Technologies (NASDAQ:IRTC) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for iRhythm Technologies and Tactile Systems Technology, as reported by MarketBeat.com.

iRhythm Technologies presently has a consensus target price of $171.7692, indicating a potential upside of 88.45%. Tactile Systems Technology has a consensus target price of $59.00, indicating a potential upside of 4.76%. Given iRhythm Technologies' higher probable upside, research analysts clearly believe iRhythm Technologies is more favorable than Tactile Systems Technology.

Profitability

This table compares iRhythm Technologies and Tactile Systems Technology's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares iRhythm Technologies and Tactile Systems Technology's gross revenue, earnings per share and valuation.

Tactile Systems Technology has lower revenue, but higher earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

iRhythm Technologies has a beta of 1.68, suggesting that its share price is 68% more volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 1.69, suggesting that its share price is 69% more volatile than the S&P 500.

Summary

Tactile Systems Technology beats iRhythm Technologies on 7 of the 12 factors compared between the two stocks.